Mark Menegus, MD
Cardiovascular Disease · Bronx, NYNPI 1174613079
Payments from drug & device makers
Across 113 payments — averaging $1800.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cardiovascular Systems Inc.$118K
- Abbott$82K
- Medtronic$1K
- Boston Scientific$1K
- Abiomed$654
- Shockwave Medical, Inc$376
- plus $524 from 11 others
Across 1 payment — averaging $1600.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$2K
What the payments were for
- Travel & lodging$70%
- Food & beverage$4,29698%
- Education$892%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cardiovascular Systems Inc. | 23 | $117,763 |
| Abbott | 31 | $81,842 |
| Medtronic(2 entities) | 17 | $1,276 |
| Boston Scientific | 13 | $1,042 |
| Abiomed | 6 | $654 |
| Shockwave Medical, Inc | 3 | $376 |
| Terumo Medical Corporation | 1 | $100 |
| Actelion Pharmaceuticals US, Inc. | 1 | $89 |
| Bristol Myers Squibb | 4 | $78 |
| Johnson & Johnson | 2 | $48 |
| Penumbra, Inc. | 3 | $44 |
| AstraZeneca | 3 | $43 |
| Chiesi USA, Inc. | 2 | $42 |
| Stryker | 1 | $24 |
| Amgen | 1 | $22 |
| Merck | 1 | $20 |
| Cardinal Health 200 LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$424
- CoreValve Evolut$315
- RESOLUTE ONYX$254
- Optis Coronary Imaging System$243
- GENERAL - STENTS$229
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$223
- ONYX FRONTIER$177
- Vascular Lithotripsy$152
- Diamondback Coronary$149
- AVVIGO Guidance System$148
- SYNERGY$148
- COREVALVE EVOLUT R$136
- GENERAL ULTRASOUND$125
- FFRangio$119
- OPTIS$101
- METACROSS OTW$100
- ANGIO-SEAL$100
- TR Band$100
- Heartrail$100
How this compares
$203,476 in reported general payments places this provider in the 95th percentile of 2,302 cardiovascular disease providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 21 | $20,605 |
| Ezetimibe | 32 | $1,227 |
| Atorvastatin Calcium | 76 | $1,128 |
| Metoprolol Succinate | 49 | $1,071 |
| ClopidogrelClopidogrel Bisulfate | 36 | $805 |
| Lisinopril | 14 | $388 |
| Spironolactone | 12 | $201 |
| Metoprolol Tartrate | 13 | $196 |
| Rosuvastatin Calcium | 16 | $184 |
| Amlodipine Besylate | 19 | $163 |
| Atenolol | 17 | $105 |
| Furosemide | 12 | $21 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Bronx
- Luigi di BiaseBronx$2.5M
- Joseph HelftBronx$488K
- Michele NannaBronx$353K
- James MinNew York$41.1M
- Robert RosensonNew York$6.9M
- Roxana MehranNew York$6.4M
- Roger HajjarNew York$5.2M
- Philippe GenereuxNew York$4.4M
- Vijay IyerAmherst$4.3M
- Gregg StoneNew York$3.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.